Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Neurovirol. 2013 Aug 27;19(5):10.1007/s13365-013-0197-3. doi: 10.1007/s13365-013-0197-3

Fig. 1.

Fig. 1

Boxes represent interquartile range (IQR). Whiskers represent data points within 1.5 IQRs of the box. A significant downward linear trend was seen for plasma MMP-2 with respect to HIV progression as grouped by antibody reactivity (p < 0.001; deviation p = 0.921). Mean MMP-2 level was reduced in the HIV antibody reactive group compared to the nonreactive group (p = 0.030). When compared to the control group, MMP-2 levels differed significantly for the antibody-reactive HIV subgroup (p < 0.001) and approached significance for the very early, nonreactive HIV subgroup (p = 0.091)